Therapeutic considerations for children with invasive group a streptococcal infections: a case series report and review of the literature.
Burnett
Aaron M
AM
Department of Pediatrics, State University of New York Upstate Medical University, Syracuse, New York13210, USA.
Domachowske
Joseph B
JB
D000293:Adolescent; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007223:Infant; D007902:Length of Stay / Q000706:statistics & numerical data; D008297:Male; D012307:Risk Factors; D012772:Shock, Septic / Q000382:microbiology / Q000628:therapy; D013290:Streptococcal Infections / Q000503:physiopathology / Q000628:therapy*; D013297:Streptococcus pyogenes / Q000302:isolation & purification; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016756:Immunoglobulins, Intravenous